Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,77
KB1,26
PKN105,8106,251,00
Msft-0,77
IBM-0,52
DCX70,9770,99-0,15
PFE2,01
15.12.2017 1:36:41
Indexy online
AD Index online
select
AD Index online
 

  • 14.12.2017
Cannabis Sativa (Stuttgart)
Závěr k 14.12.2017 Změna (%) Změna (EUR) Objem obchodů (EUR)
3,97 -5,06 -0,21 17 002
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.12.2017
Popis společnosti
Obecné informace
Název společnostiCannabis Sativa Inc
TickerCBDS
Kmenové akcie:Ordinary Shares
RICCBDS.PK
ISINUS13764T1051
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2016
Poslední známé čtvrtletní výsledky30.9.2017
Počet zaměstnanců k 31.12.2016 3
Akcie v oběhu k 30.9.2017 20 950 142
MěnaUSD
Kontaktní informace
Ulice1646 W Pioneer Blvd Ste 120
MěstoMESQUITE
PSČ89027-7515
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 023 463 906

Business Summary: Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden.
Financial Summary: BRIEF: For the nine months ended 30 September 2017, Cannabis Sativa Inc revenues increased from $24K to $124K. Net loss increased from $851K to $5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Prefessional Fees increase from $572K to $3.9M (expense), General and administrative expenses - increase from $189K to $1.1M (expense).
Odvětvová klasifikace
TRBC2012Alternative Medicine
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYPersonal & Household Prods.
MGSECTORConsumer/Non-Cyclical
NAICSToilet Preparation Manufacturing
NAICSMedicinal and Botanical Manufacturing
SICToilet Preparations
SICMedicinals And Botanicals



  • Poslední aktualizace: 15.12.2017
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardStephen Downing771.10.20171.10.2017
President, DirectorDavid Tobias6529.3.201612.7.2013
Chief Executive Officer, DirectorMike Gravel8629.3.201629.3.2016
Chief Financial OfficerDonald Lundbom-20.6.201720.6.2017